{"DataElement":{"publicId":"3380239","version":"1","preferredName":"Person Hormone Receptor Treatment Plan Type","preferredDefinition":"the type of hormonal receptor status and the associated treatment plan.","longName":"3380219v1.0:3380234v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3380219","version":"1","preferredName":"Person Hormone Receptor Treatment Plan Description","preferredDefinition":"information related to a description of the hormone receptor status (ligand binding proteins that bind signaling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals) and the treatment plan (the essential treatment issues which may include the problem to be addressed, the proposed treatment, and the treatment goal).","longName":"2236731v1.0:3380217v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3380217","version":"1","preferredName":"Hormone Receptor Treatment Plan Description","preferredDefinition":"Ligand binding proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell.  The hormone receptor can be cytoplasmic/nuclear, or associated with the cell membrane in the case of receptors whose ligands cannot penetrate the membrane.:A document outlining the essential treatment issues which will be addressed. This may include the problem to be addressed, the proposed treatment, the treatment goal, the time frame to meet goals, and an estimate of the costs.:Description; a statement that represents something in words.","longName":"C28154:C60735:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone Receptor","conceptCode":"C28154","definition":"Ligand binding proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell.  The hormone receptor can be cytoplasmic/nuclear, or associated with the cell membrane in the case of receptors whose ligands cannot penetrate the membrane.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Treatment Plan","conceptCode":"C60735","definition":"A document outlining the essential treatment issues which will be addressed. This may include the problem to be addressed, the proposed treatment, the treatment goal, the time frame to meet goals, and an estimate of the costs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B97B8401-14CE-113F-E040-BB89AD431AAC","latestVersionIndicator":"Yes","beginDate":"2012-02-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-02-21","modifiedBy":"ONEDATA","dateModified":"2012-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B97B8401-14DF-113F-E040-BB89AD431AAC","latestVersionIndicator":"Yes","beginDate":"2012-02-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-02-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3380234","version":"1","preferredName":"Hormone Receptor Treatment Plan Type","preferredDefinition":"the type of hormonal receptor status and associated treatment plan.","longName":"3380234v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"90","maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"HER2+","valueDescription":"HER2+","ValueMeaning":{"publicId":"3380235","version":"1","preferredName":"HER2+","longName":"3380235","preferredDefinition":"HER2+","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B97B8401-16A9-113F-E040-BB89AD431AAC","latestVersionIndicator":"Yes","beginDate":"2012-02-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-02-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B97B8401-16C2-113F-E040-BB89AD431AAC","beginDate":"2012-02-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-02-21","modifiedBy":"ONEDATA","dateModified":"2012-02-21","deletedIndicator":"No"},{"value":"ER- and PR- and HER2-","valueDescription":"ER- and PR- and HER2-","ValueMeaning":{"publicId":"3380236","version":"1","preferredName":"ER- and PR- and HER2-","longName":"3380236","preferredDefinition":"ER- and PR- and HER2-","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B97B8401-16CC-113F-E040-BB89AD431AAC","latestVersionIndicator":"Yes","beginDate":"2012-02-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-02-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B97B8401-16E5-113F-E040-BB89AD431AAC","beginDate":"2012-02-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-02-21","modifiedBy":"ONEDATA","dateModified":"2012-02-21","deletedIndicator":"No"},{"value":"ER+ or PR+ and HER2-, plan to treat with endocrine therapy alone","valueDescription":"ER+ or PR+ and HER2-, plan to treat with endocrine therapy alone","ValueMeaning":{"publicId":"3380237","version":"1","preferredName":"ER+ or PR+ and HER2-, plan to treat with endocrine therapy alone","longName":"3380237","preferredDefinition":"ER+ or PR+ and HER2-, plan to treat with endocrine therapy alone","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B97B8401-16EF-113F-E040-BB89AD431AAC","latestVersionIndicator":"Yes","beginDate":"2012-02-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-02-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B97B8401-1708-113F-E040-BB89AD431AAC","beginDate":"2012-02-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-02-21","modifiedBy":"ONEDATA","dateModified":"2012-02-21","deletedIndicator":"No"},{"value":"ER+ or PR+ and HER2-, plan to treat with chemo +/- endocrine therapy","valueDescription":"ER+ or PR+ and HER2-, plan to treat with chemo +/- endocrine therapy","ValueMeaning":{"publicId":"3380238","version":"1","preferredName":"ER+ or PR+ and HER2-, plan to treat with chemo +/- endocrine therapy","longName":"3380238","preferredDefinition":"ER+ or PR+ and HER2-, plan to treat with chemo +/- endocrine therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B97B8401-1712-113F-E040-BB89AD431AAC","latestVersionIndicator":"Yes","beginDate":"2012-02-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-02-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B97B8401-172B-113F-E040-BB89AD431AAC","beginDate":"2012-02-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-02-21","modifiedBy":"ONEDATA","dateModified":"2012-02-21","deletedIndicator":"No"},{"value":"ER- and PR- and HER2+","valueDescription":"ER- and PR- and HER2+","ValueMeaning":{"publicId":"3626403","version":"1","preferredName":"ER- and PR- and HER2+","longName":"3626403","preferredDefinition":"ER- and PR- and HER2+","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE7B6027-7469-643C-E040-BB89AD436D12","latestVersionIndicator":"Yes","beginDate":"2012-11-14","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-11-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CE7B6027-7482-643C-E040-BB89AD436D12","beginDate":"2012-11-14","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-11-14","modifiedBy":"ONEDATA","dateModified":"2012-11-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B97B8401-1693-113F-E040-BB89AD431AAC","latestVersionIndicator":"Yes","beginDate":"2012-02-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-02-21","modifiedBy":"ZIEGLERK","dateModified":"2012-11-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"3380219v1.0:3380234v1.0","type":"USED_BY","context":"CTEP"},{"name":"3380219v1.0:3380234v1.0","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Marker Status and treatment p","type":"Preferred Question Text","description":"Marker Status and treatment plan","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Marker status","url":null,"context":"CTEP"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B97B8401-1735-113F-E040-BB89AD431AAC","latestVersionIndicator":"Yes","beginDate":"2012-02-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-02-21","modifiedBy":"FORMBUILDER","dateModified":"2014-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}